Business Express is an online portal that covers the latest developments in the world of business and finance. From startups and entrepreneurship to mergers and acquisitions, Business Express provides reporting on the stories that matter most to business leaders and decision-makers.The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.
2023 04 16T200422Z 2 LYNXMPEJ3F089 RTROPTP 4 FRANCE YNSECT
2023 04 16T200422Z 2 LYNXMPEJ3F089 RTROPTP 4 FRANCE YNSECT

France’s Ynsect to refocus bug business after capital increase


By Sybille de La Hamaide

PARIS (Reuters) – French insect-based ingredients maker Ynsect will refocus its strategy on high-margin markets like pet food, shut a production plant and cut jobs after raising 160 million euros ($177 million) from investors, its chief executive said.

The company, which is in talks for additional funding, will use the money to finance expansion of its flagship vertical insect farm in Amiens in northern France, the world’s largest, and for new projects, Antoine Hubert told Reuters in an interview.

Farmed bugs, such as mealworms, are ground down to produce proteins for aquaculture, livestock, pet food, fertilisers and human nutrition. They are considered more environmentally friendly proteins because they require less land and water than crops and emit fewer greenhouse gases.

But the technology is costly, making the meal far more expensive than its plant-based alternatives.

“In an environment where there is inflation on energy and raw materials but also on the cost of capital and debt, we cannot afford to invest loads of resources in markets which are the least remunerative (animal feed), while you have other markets where there is a lot of demand, good returns and higher margins,” Hubert said, referring to pet food, human nutrition and fertilisers.

Ynsect will close its Dutch production plant, acquired through the takeover of Protifarm in 2021, which rears a different type of bug, while keeping research activities. This will lead to 35 job cuts.

Don't miss out on any breaking news or insightful opinions!
Subscribe to our free newsletter and stay updated on the go!


By submitting this form, you are consenting to receive marketing emails from: Global Banking & Finance Review. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email.

In addition the company will cut 38 jobs in France, out of a total of about 360 people, Hubert said.

Ynsect, which announced agreements in December to build insect ingredient production sites in the United States and Mexico, has signed sales deals for 180 million euros over three years and is in talks for an additional 1 billion euros, of which more than half is for pet food, he also said.

In its latest round of fund raising in 2020 Ynsect brought in more than 315 million euros, of which about 175 million euros was capital and the rest in debt and subsidies.

($1 = 0.9051 euros)

 

(Reporting by Sybille de La Hamaide; Editing by Sharon Singleton)

 

Recent Post: